Cell Biotech Co., Ltd. (KOSDAQ:049960)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,760
+120 (0.95%)
At close: May 28, 2025, 3:30 PM KST
7.23%
Market Cap 88.49B
Revenue (ttm) 48.10B
Net Income (ttm) 13.94B
Shares Out 6.84M
EPS (ttm) 2,034.68
PE Ratio 6.35
Forward PE n/a
Dividend 450.00 (3.48%)
Ex-Dividend Date Dec 27, 2024
Volume 12,021
Average Volume 7,671
Open 12,750
Previous Close 12,640
Day's Range 12,590 - 12,760
52-Week Range 11,600 - 16,950
Beta 0.67
RSI 57.25
Earnings Date May 13, 2025

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1995
Employees 106
Stock Exchange KOSDAQ
Ticker Symbol 049960
Full Company Profile

Financial Performance

In 2024, Cell Biotech's revenue was 49.91 billion, a decrease of -7.20% compared to the previous year's 53.79 billion. Earnings were 15.13 billion, an increase of 139.96%.

Financial Statements

News

There is no news available yet.